{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:00:43Z","timestamp":1789912843472,"version":"4.0.1"},"reference-count":120,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,3,29]]},"DOI":"10.3233\/jad-180740","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T14:29:55Z","timestamp":1549981795000},"page":"459-471","source":"Crossref","is-referenced-by-count":36,"title":["The Role of Apolipoprotein E Isoforms in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"68","author":[{"given":"Alejandro R.","family":"Roda","sequence":"first","affiliation":[{"name":"Protein Design and Immunotherapy Group, Departament de Bioqu\u00edmica i Biologia Molecular, Facultat de Bioci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Montoliu-Gaya","sequence":"additional","affiliation":[{"name":"Protein Design and Immunotherapy Group, Departament de Bioqu\u00edmica i Biologia Molecular, Facultat de Bioci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona, Spain"},{"name":"Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Villegas","sequence":"additional","affiliation":[{"name":"Protein Design and Immunotherapy Group, Departament de Bioqu\u00edmica i Biologia Molecular, Facultat de Bioci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180740_ref1","doi-asserted-by":"crossref","first-page":"a006239-a006239","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-180740_ref2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis: An update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-180740_ref4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-\u03b2 synthesis and clearance rates as measured in cerebrospinal fluid","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat Med"},{"key":"10.3233\/JAD-180740_ref5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.arcmed.2012.09.009","article-title":"Pathogenesis and disease-modifying therapy in Alzheimer\u2019s disease: The flat line of progress","volume":"43","author":"Castellani","year":"2012","journal-title":"Arch Med Res"},{"key":"10.3233\/JAD-180740_ref6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","article-title":"Questions concerning the role of amyloid-\u03b2 in the definition, aetiology and diagnosis of Alzheimer\u2019s disease","volume":"136","author":"Morris","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-180740_ref7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.14348\/molcells.2014.0248","article-title":"Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: Potential cellular and molecular mechanisms","volume":"37","author":"Kim","year":"2014","journal-title":"Mol Cells"},{"key":"10.3233\/JAD-180740_ref8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/nan.12387","article-title":"Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: The pathological building blocks of early Alzheimer\u2019s disease","volume":"43","author":"Ehrenberg","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-180740_ref9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-180688","article-title":"Neuropathologic correlates of psychiatric symptoms in Alzheimer\u2019s disease","volume":"66","author":"Ehrenberg","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-180740_ref11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-180740_ref12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-180740_ref13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-180740_ref14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/JAD-2002-4303","article-title":"ApoE4: Is it the absence of good or the presence of bad?","volume":"4","author":"Ashford","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref15","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J\u00a0Biol Chem"},{"key":"10.3233\/JAD-180740_ref16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: Insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.3233\/JAD-180740_ref17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein E sets the stage: Response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.arr.2017.06.002","article-title":"Evolution of human apolipoprotein E (APOE) isoforms: Gene structure, protein function and interaction with dietary factors","volume":"37","author":"Huebbe","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-180740_ref19","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-180740_ref20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1471-4159.2004.02581.x","article-title":"Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein","volume":"90","author":"Irizarry","year":"2004","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-180740_ref21","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0508693102","article-title":"Apolipoprotein (apo) E4 enhances amyloid peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target","volume":"102","author":"Ye","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180740_ref22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.3233\/JAD-180740_ref23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0169-328X(96)00161-1","article-title":"Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer\u2019s disease brains","volume":"43","author":"Johnston","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-180740_ref24","doi-asserted-by":"crossref","first-page":"18303","DOI":"10.1073\/pnas.1314145110","article-title":"Neuroprotective sirtuin ratio reversed by ApoE4","volume":"110","author":"Theendakara","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180740_ref25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2174\/1389450111314060004","article-title":"Sirtuins as possible targets in neurodegenerative diseases","volume":"14","author":"Donmez","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.3233\/JAD-180740_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2015.10.005","article-title":"Protein structures in Alzheimer\u2019s disease: The basis for rationale therapeutic design","volume":"588","author":"Montoliu-Gaya","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"10.3233\/JAD-180740_ref27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1523\/JNEUROSCI.3562-15.2016","article-title":"Direct transcriptional effects of apolipoprotein E","volume":"36","author":"Theendakara","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref28","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1007\/s12035-017-0757-2","article-title":"Transcriptional effects of ApoE4: Relevance to Alzheimer\u2019s Disease","volume":"55","author":"Theendakara","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-180740_ref29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/WAD.0000000000000011","article-title":"Altered levels of amyloid precursor protein intracellular domain-interacting proteins in Alzheimer disease","volume":"28","author":"Chakrabarti","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-180740_ref30","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.1073\/pnas.0907652106","article-title":"Alzheimer\u2019s disease-like pathological features in transgenic mice expressing the APP intracellular domain","volume":"106","author":"Ghosal","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180740_ref31","doi-asserted-by":"crossref","first-page":"e0159435","DOI":"10.1371\/journal.pone.0159435","article-title":"Tau protein mediates APP intracellular domain (AICD)-induced Alzheimer\u2019s-like pathological features in mice","volume":"11","author":"Ghosal","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180740_ref32","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1038\/srep04618","article-title":"Pharmacological targeting of the \u03b2-amyloid precursor protein intracellular domain","volume":"4","author":"Branca","year":"2014","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180740_ref33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-180740_ref34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)32449-4","article-title":"Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis","volume":"40","author":"Winkler","year":"1999","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-180740_ref35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2014.08.005","article-title":"More than cholesterol transporters: Lipoprotein receptors in CNS function and neurodegeneration","volume":"83","author":"Lane-Donovan","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1074-5521(96)90183-0","article-title":"An ApoE-Abeta inhibition complex in Abeta fibril extension","volume":"3","author":"Wood","year":"1996","journal-title":"Chem Biol"},{"key":"10.3233\/JAD-180740_ref37","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/bi5008172","article-title":"The binding of apolipoprotein E to oligomers and fibrils of amyloid-\u03b2 alters the kinetics of amyloid aggregation","volume":"53","author":"Garai","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-180740_ref38","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","article-title":"Role of Apolipoprotein E in \u03b2-Amyloidogenesis: Isoform-specific effects on protofibril to fibril conversion of A\u03b2 and brain A\u03b2 deposition","volume":"290","author":"Hori","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180740_ref39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref40","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-\u03b2 deposition in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-180740_ref41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid \u03b2-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-180740_ref42","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1038\/s41598-017-08604-8","article-title":"Targeting apolipoprotein E\/amyloid \u03b2 binding by peptoid CPO_A\u03b217-21 P ameliorates Alzheimer\u2019s disease related pathology and cognitive decline","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180740_ref43","doi-asserted-by":"publisher","DOI":"10.15761\/JSIN.1000168"},{"key":"10.3233\/JAD-180740_ref44","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.0000000000004336","article-title":"APOE genotype and early \u03b2-amyloid accumulation in older adults without dementia","volume":"89","author":"Lim","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-180740_ref45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-180740_ref46","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"ApoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-180740_ref47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt110","article-title":"Reduction of low-density lipoprotein receptor-related protein (LRP1) in hippocampal neurons does not proportionately reduce, or otherwise alter, amyloid deposition in APPswe\/PS1dE9 transgenic mice","volume":"4","author":"Xu","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180740_ref48","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","article-title":"LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer\u2019s amyloid-\u03b2","volume":"32","author":"Kanekiyo","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref49","doi-asserted-by":"crossref","first-page":"e11884","DOI":"10.1371\/journal.pone.0011884","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking","volume":"5","author":"Fuentealba","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180740_ref50","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","article-title":"Neuronal clearance of amyloid- \u03b2 by endocytic receptor LRP1","volume":"33","author":"Kanekiyo","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref51","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","article-title":"Astrocytic LRP1 mediates brain A\u03b2 clearance and impacts amyloid deposition","volume":"37","author":"Liu","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-016-0099-y","article-title":"Apolipoprotein E lipoprotein particles inhibit amyloid-\u03b2 uptake through cell surface heparan sulphate proteoglycan","volume":"11","author":"Fu","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-180740_ref53","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neurobiolaging.2014.03.037","article-title":"Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer\u2019s disease","volume":"35","author":"Poirier","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180740_ref54","doi-asserted-by":"crossref","first-page":"89ra57-89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid- \u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-180740_ref55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","article-title":"Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning","volume":"11","author":"Poirier","year":"1991","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-180740_ref56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: Brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-180740_ref58","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1074\/mcp.M115.056580","article-title":"Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease","volume":"15","author":"Sweet","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"10.3233\/JAD-180740_ref59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients","volume":"122","author":"Ji","year":"2003","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-180740_ref60","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons","volume":"29","author":"Dumanis","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref61","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/cns.12720","article-title":"Hippocampal synaptic and neural network deficits in young mice carrying the human gene","volume":"23","author":"Sun","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-180740_ref62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.dadm.2014.11.014","article-title":"Behavioral testing affects the phenotypic expression of APOE \u025b3 and APOE \u025b4 in targeted replacement mice and reduces the differences between them","volume":"1","author":"Salomon-Zimri","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-180740_ref63","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","article-title":"Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-deficient mice","volume":"36","author":"Lane-Donovan","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref64","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1073\/pnas.1609896113","article-title":"Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes","volume":"113","author":"Chung","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180740_ref65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-150381","article-title":"Treatment of Alzheimer\u2019s disease: The legacy of the cholinergic hypothesis, neuroplasticity, and future directions","volume":"47","author":"Ashford","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","article-title":"A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60","volume":"293","author":"Cao","year":"2001","journal-title":"Science"},{"key":"10.3233\/JAD-180740_ref67","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref68","doi-asserted-by":"crossref","first-page":"12230","DOI":"10.1523\/JNEUROSCI.1694-14.2014","article-title":"Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid \u03b2","volume":"34","author":"Ma","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.3233\/JAD-180740_ref69","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1523\/JNEUROSCI.2552-14.2015","article-title":"Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Hall","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuron.2017.11.028","article-title":"Alzheimer\u2019s disease: From firing instability to homeostasis network collapse","volume":"97","author":"Frere","year":"2018","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref71","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.3233\/JAD-180740_ref72","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ajpath.2013.05.009","article-title":"APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease","volume":"183","author":"Yang","year":"2013","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-180740_ref73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40478-016-0339-y","article-title":"The relationship between complement factor C3, APOE \u025b4, amyloid and tau in Alzheimer\u2019s disease","volume":"4","author":"Bonham","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-180740_ref74","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archneurol.2012.277","article-title":"Plasma signaling proteins in persons at genetic risk for Alzheimer disease: Influence of APOE genotype","volume":"69","author":"Ringman","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-180740_ref75","doi-asserted-by":"crossref","first-page":"e183597","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of chronic low-grade inflammation with risk of Alzheimer disease in carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-180740_ref76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2011.01.005","article-title":"Mechanism mediating oligomeric A\u03b2 clearance by na\u00efve primary microglia","volume":"42","author":"Yang","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-180740_ref77","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.22988","article-title":"Targeting microglia for the treatment of Alzheimer\u2019s disease","volume":"64","author":"Wes","year":"2016","journal-title":"Glia"},{"key":"10.3233\/JAD-180740_ref78","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1096\/fj.201600677RR","article-title":"Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on \u03c9-3 supplementation","volume":"31","author":"Famenini","year":"2017","journal-title":"FASEB J"},{"key":"10.3233\/JAD-180740_ref79","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","article-title":"Microglial genes regulating neuroinflammation in the progression of Alzheimer\u2019s disease","volume":"36","author":"Villegas-Llerena","year":"2016","journal-title":"Curr Opin Neurobiol"},{"key":"10.3233\/JAD-180740_ref80","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.3233\/JAD-180740_ref81","doi-asserted-by":"crossref","first-page":"24504","DOI":"10.1074\/jbc.M700618200","article-title":"Insensitivity to A\u03b242-lowering nonsteroidal anti-inflammatory drugs and \u03b3-secretase inhibitors is common among aggressive presenilin-1 mutations","volume":"282","author":"Czirr","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180740_ref82","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: Brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-180740_ref83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","article-title":"Dyslipidemia and the risk of Alzheimer\u2019s disease","volume":"15","author":"Reitz","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.3233\/JAD-180740_ref84","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/iub.1091","article-title":"Cholesterol and Alzheimer\u2019s disease: A still poorly understood correlation","volume":"64","author":"Ricciarelli","year":"2012","journal-title":"IUBMB Life"},{"key":"10.3233\/JAD-180740_ref85","doi-asserted-by":"crossref","first-page":"e1002265","DOI":"10.1371\/journal.pmed.1002265","article-title":"Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study","volume":"14","author":"Schilling","year":"2017","journal-title":"PLoS Med"},{"key":"10.3233\/JAD-180740_ref86","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-180740_ref87","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-180740_ref88","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2016.3783","article-title":"Sex and race differences in the association between statin use and the incidence of Alzheimer disease","volume":"74","author":"Zissimopoulos","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-180740_ref89","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180740_ref90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: Insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.3233\/JAD-180740_ref91","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1194\/jlr.R075630","article-title":"Cellular cholesterol homeostasis and Alzheimer\u2019s disease","volume":"58","author":"Chang","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.3233\/JAD-180740_ref92","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnen\/nlw067","article-title":"Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid","volume":"75","author":"Heinsinger","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-180740_ref93","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","article-title":"Dyslipidemia and the risk of Alzheimer\u2019s disease","volume":"15","author":"Reitz","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.3233\/JAD-180740_ref94","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides","volume":"348 Pt 2","author":"Tokuda","year":"2000","journal-title":"Biochem J"},{"key":"10.3233\/JAD-180740_ref95","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of Apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref96","doi-asserted-by":"crossref","first-page":"e002886","DOI":"10.1161\/JAHA.115.002886","article-title":"ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"5","author":"Yassine","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.3233\/JAD-180740_ref97","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0301-4622(02)00300-9","article-title":"Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: Correlation with protein stability?","volume":"100","author":"Weers","year":"2003","journal-title":"Biophys Chem"},{"key":"10.3233\/JAD-180740_ref98","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M511077200","article-title":"Structural and functional variations in human Apolipoprotein E3 and E4","volume":"281","author":"Chou","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180740_ref99","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/bi060023b","article-title":"Effect of carboxyl-terminal truncation on structure and lipid interaction of human Apolipoprotein E4","volume":"45","author":"Tanaka","year":"2006","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-180740_ref100","doi-asserted-by":"crossref","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","article-title":"Structure-dependent impairment of intracellular Apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors","volume":"286","author":"Brodbeck","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180740_ref101","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12263-014-0397-3","article-title":"Adenosine triphosphate concentrations are higher in the brain of APOE3- compared to APOE4-targeted replacement mice and can be modulated by curcumin","volume":"9","author":"Chin","year":"2014","journal-title":"Genes Nutr"},{"key":"10.3233\/JAD-180740_ref102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-100129","article-title":"Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE \u025b4 allele, the major late-onset Alzheimer\u2019s susceptibility gene","volume":"22","author":"Valla","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref103","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-151205","article-title":"Altered energy metabolism pathways in the posterior cingulate in young adult Apolipoprotein E \u025b4 carriers","volume":"53","author":"Perkins","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref104","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11910-016-0643-8","article-title":"New genetic approaches to AD: Lessons from APOE-TOMM40 phylogenetics","volume":"16","author":"Lutz","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-180740_ref105","first-page":"12","article-title":"The broad impact of TOM40 on neurodegenerative diseases in aging","volume":"1","author":"Gottschalk","year":"2014","journal-title":"J Parkinsons Dis Alzheimers Dis"},{"key":"10.3233\/JAD-180740_ref106","doi-asserted-by":"crossref","first-page":"e0180356","DOI":"10.1371\/journal.pone.0180356","article-title":"APOE \u025b4-TOMM40 \u2019523 haplotypes and the risk of Alzheimer\u2019s disease in older Caucasian and African Americans","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180740_ref107","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jalz.2018.01.015","article-title":"The effects of the TOMM40 poly-T alleles on Alzheimer\u2019s disease phenotypes","volume":"14","author":"Chiba-Falek","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180740_ref108","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"key":"10.3233\/JAD-180740_ref109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-180740_ref110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"key":"10.3233\/JAD-180740_ref111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-180740_ref112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-180740_ref113","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2990.2008.00997.x","article-title":"The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer\u2019s disease. A precocious onset?","volume":"35","author":"Grinberg","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-180740_ref114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.09.007","article-title":"Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer\u2019s disease Braak stages: A quantitative study in humans","volume":"61","author":"Theofilas","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180740_ref115","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180740_ref116","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180740_ref117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","article-title":"Association of APOE with tau-tangle pathology with and without \u03b2-amyloid","volume":"37","author":"Farfel","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180740_ref118","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.3233\/JAD-180740_ref119","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1038\/s41598-017-14204-3","article-title":"CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer\u2019s disease","volume":"7","author":"Koch","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180740_ref120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-016-0361-4","article-title":"Apolipoprotein E as a therapeutic target in Alzheimer\u2019s disease: A review of basic research and clinical evidence","volume":"30","author":"Yamazaki","year":"2016","journal-title":"CNS Drugs"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:08Z","timestamp":1777370948000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":120,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-180740","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]}}}